CWS
NVO

Confluence Wealth Services’s Novo Nordisk NVO Stock Holding History

Confluence Wealth Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,354
Closed -$280K – 345
2024
Q3 		$280K Sell
2,354
-500
-18% -$66.7K 0.02% 292
2024
Q2 		$407K Buy
2,854
+166
+6% +$22K 0.03% 250
2024
Q1 		$345K Buy
2,688
+644
+32% +$76.7K 0.03% 253
2023
Q4 		$211K Sell
2,044
-264
-11% -$26.1K 0.02% 281
2023
Q3 		$210K Buy
+2,308
New +$203K 0.04% 249

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Confluence Wealth Services's NVO Position: Q4 2024 in Review

Confluence Wealth Services sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,354 shares — an estimated $280K sold.

Confluence Wealth Services first reported a position in NVO in Q3 2023 and held it in 5 quarters. The position peaked at $407K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Confluence Wealth Services reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Confluence Wealth Services sold 2,354 Novo Nordisk shares in Q4 2024, an estimated $280K.
  • Confluence Wealth Services first reported a position in Novo Nordisk in Q3 2023 and held it in 5 quarters.
  • Confluence Wealth Services's Novo Nordisk position peaked at $407K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Confluence Wealth Services's 13F filing for Q4 2024, filed 27 Jan 2025.